Azurity Pharmaceuticals and Sebela Pharmaceuticals announced today Azurity’s successful acquisition of Sebela’s Bowel Prep Franchise, including two leading bowel preparation therapies for ...

All adverse outcomes were of mild or moderate severity, and no significant trends were observed on the basis of LVEF status. The most common adverse events were hypotension (33%-36.4%), arrhythmia ...

Abbott Laboratories is reportedly in the final stages of negotiating a takeover of Exact Sciences Corp, a company known for ...

Medical device maker Abbott Laboratories is nearing a potential takeover of cancer test maker Exact Sciences Corp, Bloomberg ...

Madison, Wisconsin-based Exact Sciences develops cancer screening and diagnostic tests. Its portfolio includes established brands like Cologuard and Oncotype Dx, alongside the Cancerguard test for ...

As screening guidelines evolve and GI care increasingly shifts to outpatient settings, ASCs are seeing significant growth in colonoscopy volume. Here are ten developments shaping that trend: ...

Approximately 20% of new lung cancer diagnoses occur in nonsmokers in the U.S., according to The Ohio State University ...

Gastrointestinal procedures continue to dominate the ASC landscape in 2025, driven by increased screening demand, younger-onset colorectal cancer and ongoing migration of cases out of hospitals. All ...

Scientists have created swallowable microsphere “pills” packed with engineered bacteria that can detect signs of gut disease, ...

Move over, colonoscopies—researchers report in ACS Sensors that they've developed a sensor made of tiny microspheres packed ...

In this fictional tale, a skeptical physician’s scrutiny reshapes a sales rep’s journey and forces truth to prevail over glossy marketing claims.

USG presidential candidates Aum Dhruv ’27 and Quentin Colón Roosevelt ’27 share similar views on University collaboration ...